BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27906673)

  • 1. Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.
    Wang J; Ai X; Qin T; Xu Z; Zhang Y; Liu J; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Cai W; Ru K; Jia Y; Huang G; Xiao Z
    Oncotarget; 2017 Jan; 8(1):1603-1612. PubMed ID: 27906673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients.
    Ma J; Ai X; Wang J; Xing L; Tian C; Yang H; Yu Y; Zhao H; Wang X; Zhao Z; Wang Y; Cao Z
    Ann Hematol; 2021 Sep; 100(9):2207-2214. PubMed ID: 33990890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization for detecting chromosome abnormalities in myelodysplastic syndromes: A retrospective study.
    Ai X; Li B; Xu Z; Liu J; Qin T; Li Q; Xiao Z
    Medicine (Baltimore); 2021 May; 100(18):e25768. PubMed ID: 33950965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes?
    Yang W; Stotler B; Sevilla DW; Emmons FN; Murty VV; Alobeid B; Bhagat G
    Leuk Res; 2010 Apr; 34(4):420-5. PubMed ID: 19800120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic methods in the diagnosis of myelodysplastic syndromes. A review.
    Lukackova R; Gerykova Bujalkova M; Majerova L; Mladosievicova B
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):339-45. PubMed ID: 24263214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
    Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T
    Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].
    Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
    Schwabkey ZI; Al Ali N; Chan O; Sallman DA; Padron E; Kuykendall AT; Talati C; Sweet K; Lancet JE; Komrokji RS
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e52-e56. PubMed ID: 33093008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
    Wall M
    Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of miscarriage products using multiplex ligation-dependent probe amplification (MLPA): alternative to conventional karyotype analysis.
    Kim JW; Lyu SW; Sung SR; Park JE; Cha DH; Yoon TK; Ko JJ; Shim SH
    Arch Gynecol Obstet; 2015 Feb; 291(2):347-54. PubMed ID: 25115280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].
    Wang W; Chen Z; Yu M; Wang H; Lou J; Xu H; Hu C; Mu Q; Tong H; Wei J; Zhou X; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):818-23. PubMed ID: 26477758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
    Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
    Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.
    van Spronsen MF; Ossenkoppele GJ; Westers TM; van de Loosdrecht AA
    Eur J Cancer; 2016 Mar; 56():10-20. PubMed ID: 26798967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic profile in patients with primary myelodysplastic syndrome].
    Gritsaev SV; Martynkevich IS; Petrova EV; Martynenko LS; Ivanova MP; Aksenova VIu; Tsybakova NIu; Potikhonova NA; Abdulkadyrov KM
    Ter Arkh; 2013; 85(7):43-9. PubMed ID: 24137946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic classification of MDS is improved by the inclusion of FISH panel testing with conventional cytogenetics.
    Kokate P; Dalvi R; Koppaka N; Mandava S
    Cancer Genet; 2017 Oct; 216-217():120-127. PubMed ID: 29025586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
    Gao DG; Li BT; Zhou LN; Chen H; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
    Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
    Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenomic array detects a subset of myelodysplastic syndrome with increased risk that is invisible to conventional karyotype.
    Choi SM; Van Norman SB; Bixby DL; Shao L
    Genes Chromosomes Cancer; 2019 Nov; 58(11):756-774. PubMed ID: 31334569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?
    Merkel D; Soffer S; Novikov I; Avigdor A; Amariglio N; Nagler A; Trakhtenbrot L
    Leuk Lymphoma; 2019 Mar; 60(3):764-771. PubMed ID: 30187812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
    Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.